G D'Eramo

569 total citations
31 papers, 453 citations indexed

About

G D'Eramo is a scholar working on Pulmonary and Respiratory Medicine, Urology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G D'Eramo has authored 31 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 10 papers in Urology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G D'Eramo's work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Hormonal and reproductive studies (9 papers). G D'Eramo is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Hormonal and reproductive studies (9 papers). G D'Eramo collaborates with scholars based in Italy. G D'Eramo's co-authors include F. Di Silverio, Alessandro Sciarra, F Sciarra, Salvatore Monti, Eleonora Palma, Carla Lubrano, Paolo Casale, Maurizio Buscarini, Vincenzo Toscano and Gerardo Flammia and has published in prestigious journals such as European Urology, Urology and Histopathology.

In The Last Decade

G D'Eramo

28 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G D'Eramo Italy 11 224 216 162 79 73 31 453
Amir Kazzazi United States 9 219 1.0× 198 0.9× 112 0.7× 89 1.1× 57 0.8× 23 378
Lea R. Gordon United States 8 105 0.5× 108 0.5× 114 0.7× 23 0.3× 90 1.2× 15 336
Takayuki Kasahara Japan 10 33 0.1× 40 0.2× 121 0.7× 26 0.3× 110 1.5× 16 372
Hai-mei Tian China 6 13 0.1× 14 0.1× 90 0.6× 80 1.0× 107 1.5× 16 376
Chen Xia China 9 6 0.0× 17 0.1× 47 0.3× 11 0.1× 103 1.4× 23 328
Laura Castello Italy 11 25 0.1× 10 0.0× 21 0.1× 7 0.1× 85 1.2× 13 360
Chie Tomida Japan 12 9 0.0× 34 0.2× 11 0.1× 20 0.3× 103 1.4× 20 391
Yuzhe Tang China 10 15 0.1× 122 0.6× 5 0.0× 8 0.1× 146 2.0× 25 343
F. Liu United States 6 5 0.0× 18 0.1× 99 0.6× 15 0.2× 114 1.6× 8 344

Countries citing papers authored by G D'Eramo

Since Specialization
Citations

This map shows the geographic impact of G D'Eramo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G D'Eramo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G D'Eramo more than expected).

Fields of papers citing papers by G D'Eramo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G D'Eramo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G D'Eramo. The network helps show where G D'Eramo may publish in the future.

Co-authorship network of co-authors of G D'Eramo

This figure shows the co-authorship network connecting the top 25 collaborators of G D'Eramo. A scholar is included among the top collaborators of G D'Eramo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G D'Eramo. G D'Eramo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salciccia, Stefano, Alessandro Sciarra, Martina Maggi, et al.. (2018). Loss of Renal Function After Retrograde Ureteral Placement of an Allium Stent for Severe Ureteral Stricture. Journal of Endourology Case Reports. 4(1). 9–11.
2.
Sciarra, Alessandro, et al.. (2005). Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate. Urology. 66(6). 1218–1222. 21 indexed citations
3.
Sciarra, Alessandro, Salvatore Monti, Luigi Mazzone, et al.. (2003). Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: Predictive value of serum chromogranin A. The Prostate. 58(4). 421–428. 32 indexed citations
4.
Morgante, Emanuela, Roberto Gradini, Massimo Realacci, et al.. (2001). Effects of long‐term treatment with the anti‐androgen bicalutamide on human testis: an ultrastructural and morphometric study. Histopathology. 38(3). 195–201. 6 indexed citations
5.
Sciarra, Alessandro, G D'Eramo, Paolo Casale, et al.. (1998). Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. The Prostate. 34(2). 121–128. 36 indexed citations
6.
Silverio, F. Di, Salvatore Monti, Alessandro Sciarra, et al.. (1998). Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. The Prostate. 37(2). 77–83. 87 indexed citations
8.
Silverio, F. Di, G D'Eramo, Maurizio Buscarini, et al.. (1996). DIMA Ploidy, Gleason Score,Pathological Stage and Serum PSALevels as Predictors of Disease-FreeSurvival in C-D(1) Prostatic CancerPatients Submitted to RadicalRetropubic Prostatectomy. European Urology. 30(3). 316–321. 17 indexed citations
9.
Silverio, F. Di, et al.. (1995). Is medical therapy an expensive way for delaying surgery in BPH patients?. PubMed. 47(4). 177–84. 3 indexed citations
10.
11.
Sciarra, F, Salvatore Monti, Eleonora Palma, et al.. (1995). Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue. Urological Research. 23(6). 387–390. 16 indexed citations
12.
D'Eramo, G, et al.. (1995). Is there always a role for radical prostatectomy in the treatment of localized prostate cancer?. PubMed. 47(3). 117–24. 3 indexed citations
13.
Sciarra, Alessandro, et al.. (1993). Plant extracts in BPH.. PubMed. 45(4). 143–9. 21 indexed citations
14.
Silverio, F. Di, G D'Eramo, Flavia Persechino, et al.. (1992). The Prognostic Value of DNA Content in Patients with Prostatic Carcinoma. European Urology. 21(1). 92–95. 4 indexed citations
15.
Silverio, F. Di, et al.. (1992). New Ultrasensitive Assay Development by Using Monoclonal Antibodies for Detecting Prostate-Specific Antigen. European Urology. 21(1). 79–82. 1 indexed citations
16.
Silverio, F. Di, G D'Eramo, Carla Lubrano, et al.. (1992). Evidence that Serenoa repens Extract Displays an Antiestrogenic Activity in Prostatic Tissue of Benign Prostatic Hypertrophy Patients. European Urology. 21(4). 309–314. 82 indexed citations
17.
Silverio, F. Di, et al.. (1991). Surgery of Pulmonary Metastases from Renal and Bladder Carcinoma. Scandinavian Journal of Urology and Nephrology. 25(sup138). 215–218. 1 indexed citations
18.
Silverio, F. Di, F Sciarra, & G D'Eramo. (1990). Advanced Prostatic Cancer: Clinical and Hormonal Response to Flutamide in Patients Pretreated with LHRH Analogue andCyproterone Acetate. European Urology. 18(1). 10–15. 8 indexed citations
19.
Silverio, F. Di, et al.. (1990). Zoladex vs. Zoladex Plus Cyproterone Acetate in theTreatment of Advanced Prostatic Cancer:A Multicenter Italian Study. European Urology. 18(3). 54–61. 33 indexed citations
20.
Silverio, F. Di, Francesca Sciarra, G D'Eramo, & R. Tenaglia. (1990). Incidental Prostatic Carcinoma: Four-Year Follow-Up after Treatment with Cyproterone Acetate. European Urology. 18(4). 263–266. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026